Michael Yang
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Michael Yang
The proxy statement of Acadia Pharmaceuticals Inc reports total compensation of $2,620,679 for Michael Yang in fiscal 2020, including a base salary of $516,805. Disclosed compensation is on record for 3 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Acadia Pharmaceuticals Inc (ACAD)
Proxy statement
Start not stated–2020-04-29
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Acadia Pharmaceuticals Inc (ACAD) | Commercial Officer | $516,805 | $2,620,679 |
| 2019 | Acadia Pharmaceuticals Inc (ACAD) | Commercial Officer | $500,701 | $2,943,821 |
| 2018 | Acadia Pharmaceuticals Inc (ACAD) | Commercial Officer | $485,250 | $3,182,910 |
Recent activity
No call appearances or filed executive changes recorded yet.